4.7 Article

Thyroid status, cardiovascular risk, and mortality in older adults

Journal

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Volume 295, Issue 9, Pages 1033-1041

Publisher

AMER MEDICAL ASSOC
DOI: 10.1001/jama.295.9.1033

Keywords

-

Funding

  1. NHLBI NIH HHS [N01-HC-85080, N01-HC-85079, N01-HC-85083, N01HC85079, N01-HC-85085, N01-HC-85082, N01HC85086, N01 HC035129, N01-HC-85084, N01-HC-85086, N01 HC015103, N01-HC-85081] Funding Source: Medline
  2. NIA NIH HHS [K23 AG019161, K23-AG19161] Funding Source: Medline

Ask authors/readers for more resources

Context Previous studies have suggested that subclinical abnormalities in thyroid-stimulating hormone levels are associated with detrimental effects on the cardiovascular system. Objective To determine the relationship between baseline thyroid status and incident atrial fibrillation, incident cardiovascular disease, and mortality in older men and women not taking thyroid medication. Design, Setting, and Participants A total of 3233 US community-dwelling individuals aged 65 years or older with baseline serum thyroid-stimulating hormone levels were enrolled in 1989-1990 in the Cardiovascular Health Study, a large, prospective cohort study. Main Outcome Measures Incident atrial fibrillation, coronary heart disease, cerebrovascular disease, cardiovascular death, and all-cause death assessed through June 2002. Analyses are reported for 4 groups defined according to thyroid function test results: subclinical hyperthyroidism, euthyroidism, subclinical hypothyroidism, and overt hypothyroidism. Results Individuals with overt thyrotoxicosis ( n = 4) were excluded because of small numbers. Eighty-two percent of participants ( n = 2639) had normal thyroid function, 15% ( n = 496) had subclinical hypothyroidism, 1.6% ( n = 51) had overt hypothyroidism, and 1.5% ( n = 47) had subclinical hyperthyroidism. After exclusion of those with prevalent atrial fibrillation, individuals with subclinical hyperthyroidism had a greater incidence of atrial fibrillation compared with those with normal thyroid function ( 67 events vs 31 events per 1000 person-years; adjusted hazard ratio, 1.98; 95% confidence interval, 1.29-3.03). No differences were seen between the subclinical hyperthyroidism group and euthyroidism group for incident coronary heart disease, cerebrovascular disease, cardiovascular death, or all-cause death. Likewise, there were no differences between the subclinical hypothyroidism or overt hypothyroidism groups and the euthyroidism group for cardiovascular outcomes or mortality. Specifically, individuals with subclinical hypothyroidism had an adjusted hazard ratio of 1.07 ( 95% confidence interval, 0.90-1.28) for incident coronary heart disease. Conclusion Our data show an association between subclinical hyperthyroidism and development of atrial fibrillation but do not support the hypothesis that unrecognized subclinical hyperthyroidism or subclinical hypothyroidism is associated with other cardiovascular disorders or mortality.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available